The first thing I want to do is to get a new one. The company has been retired for more than five years, but in the last two years, it has been experiencing frequent urinary problems, always feeling unclean and having to get up several times at night. The company’s main goal is to provide a solution to the problem of the problem. The most common type of incidental cancer is the focal type, which is small in size, well differentiated and slow in growth, so it can remain in a latent state for a long time, with little chance of disease progression and metastasis, so the prognosis is good. If the tumor is of diffuse type, with large size and poor cell differentiation, it is prone to disease progression and metastasis, and about 1/3 of them can evolve into clinical prostate cancer (clinical cancer). Clinical cancer refers to prostate cancer with symptoms of prostate cancer, or adjuvant examinations (rectal examination, transrectal ultrasound and serum prostate specific antigen determination, etc.) suspected to be cancer, and confirmed by prostate biopsy pathology. The progression of incidental cancer to clinical cancer often indicates local recurrence or metastasis, and the prognosis is poor. The question of whether patients with incidental carcinoma need further treatment after prostatectomy varies from one school of thought to another. It is generally believed that for those with limited cancer foci and good pathological differentiation of the resected specimen, no further treatment can be done and there is no impact on the patient’s natural life expectancy, but regular follow-up should be performed to detect its possible progression at an early stage. For those who have diffuse cancer foci or their number is more than 3, the cancer foci occupy more than 5% of the whole resected tissue or less than 5% but the tumor cells are poorly differentiated, although the resection of hyperplastic prostate tissue has been done, there may be a certain percentage of cancer foci remaining and therefore more aggressive treatment should be taken. Usually, radical prostatectomy, radiotherapy and endocrine therapy can be used depending on the patient’s age and general condition. The current widely used treatment for incidental carcinoma is bilateral orchiectomy (debulking surgery) coupled with anti-androgenic endocrine therapy. For patients with incidental carcinoma who are relatively young, in good general condition and with cancer foci confined to the prostate envelope, early radical surgery should be pursued, which can effectively prevent metastasis and have better long-term effects. The effect of radiotherapy on the treatment of incidental cancer is not very certain, and this therapy is gradually being replaced by endocrine therapy, so it is an adjuvant therapy. After carefully inquiring about his pathological results, Professor Yao suggested that he should undergo radical surgery for prostate cancer, but since he had just undergone electrodesection of the prostate, Professor Yao suggested that he should take oral medication for now and be admitted to the hospital for radical surgery after three months. The first thing you need to do is to look for changes in the prostate-specific antigen (PSA), which is a specific marker of the prostate gland and can be used to monitor the prognosis of incidental cancer, although it is not very specific in the diagnosis of incidental cancer. It is important to come to the hospital once a month before surgery to check the PSA and closely monitor the changes in prostate cancer. After listening to Professor Yao’s explanation, he learned that his condition needed further treatment and that the treatment was effective, so the stone fell from his heart and he went back to prepare for the next step of surgery with confidence.